Page last updated: 2024-11-10

silver diethyldithiocarbamate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3034078
SCHEMBL ID900375
MeSH IDM0042329

Synonyms (46)

Synonym
nsc-378347
1470-61-7
D1401
silver diethyldithiocarbamate
diethyldithiocarbamic acid silver salt
D0490
agddtc
silver n,n-diethyldithiocarbamate
nsc 378347
silver n,n-diethylcarbamodithioate
diethyl dithio carbamic acid silver salt
FT-0656195
A808594
diethyldithiocarbamic acid silver salt - brucine
silver diethyldithiocarbamate - brucine
einecs 253-895-7
38351-46-1
diethyldithiocarbamic acid, silver salt
einecs 216-003-7
unii-gvn001b86o
gvn001b86o ,
(diethyldithiocarbamato-s,s')silver
silver, (diethylcarbamodithioato-s,s')-
silver, (diethylcarbamodithioato-kappas,kappas')-
AKOS015914863
silver(1+) (diethylcarbamothioyl)sulfanide
SCHEMBL900375
silver, (diethyldithiocarbamato)-
(diethyldithiocarbamato)silver
silver, (diethylcarbamodithioato-.kappa.s,.kappa.s')-
carbamodithioic acid, diethyl-, silver(1+) salt
ditiocarb silver
silver(1+) diethyldithiocarbamate
(diethyldithiocarbamate)silver
silverdiethyldithiocarbamate
diethyldithiocarbamic acid,silver salt
silver (i) diethyldithiocarbamate
AS-64941
J-008309
Q3032710
silver diethyl dithiocarbamate
silver;n,n-diethylcarbamodithioate
DTXSID20933003
silver(1+) diethylcarbamodithioate
4-(2,4-difluorophenoxy)-n-hydroxy-3-nitrobenzenecarboximidamide
D95253
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (25.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 40.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index40.74 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.04 (4.65)
Search Engine Demand Index54.47 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (40.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]